HIV+Hep in the News

HIV+Hepatitis Policy Institute, an advocacy group, criticized the proposed rules impact on patients, saying the government is still letting pharmacy benefit managers (PBMs) profit from copay assistance. The rule included no requirements that copay assistance be counted as part of patient cost-sharing, and no provision closing an essential health benefits loophole. “Coming from an administration that prides itself on supporting patients and lowering their prescription drug costs, this is a huge disappointment,” said Carl Schmid, executive director at the institute. “While they have gone on record that they will issue these rules, the clock is ticking and there isn’t much time left.”